In prior research involving metastatic breast cancer patients, nab-paclitaxel had produced significantly higher anti-tumor activity than solvent-based paclitaxel.
前期的研究包括转移性乳腺癌患者，蛋白结合型紫杉醇在抗肿瘤作用比单纯的紫杉醇溶剂要强。
In prior research involving metastatic breast cancer patients, nab-paclitaxel had produced significantly higher anti-tumor activity than solvent-based paclitaxel.
前期的研究包括转移性乳腺癌患者，蛋白结合型紫杉醇在抗肿瘤作用比单纯的紫杉醇溶剂要强。
应用推荐